ED
PLXP

Exane Derivatives’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Exane Derivatives’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$16K Sell
6,575
-6,832
-51% -$19K 0.01% 372
2022
Q1 		$54.2K Buy
+13,407
New +$73.5K 0.02% 560

Other funds holding PLXP

MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Exane Derivatives's PLXP Position: Q2 2022 in Review

Exane Derivatives reduced its PLx Pharma Inc. Common Stock (PLXP) stake by 51% in Q2 2022, selling an estimated $19K and leaving 6,575 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #372.

Exane Derivatives first reported a position in PLXP in Q1 2022 and has held it in 2 quarters since. The position peaked at $54.2K in Q1 2022. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

  • Exane Derivatives held 6,575 shares of PLx Pharma Inc. Common Stock worth $16K as of Q2 2022.
  • Exane Derivatives sold 6,832 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $19K.
  • PLx Pharma Inc. Common Stock made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #372 holding.
  • Exane Derivatives first reported a position in PLx Pharma Inc. Common Stock in Q1 2022 and has held it in 2 quarters since.
  • Exane Derivatives's PLx Pharma Inc. Common Stock position peaked at $54.2K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.